FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3038961723> ?p ?o ?g. }

• W3038961723 abstract "Abstract Heparan sulfate proteoglycan 2 (HSPG2), also known as perlecan, is a large multi-domain extracellular matrix proteoglycan, which contributes to the invasion, metastasis and angiogenesis of solid tumor. However, very little is known about the effect of HSPG2 on acute myeloid leukemia (AML). This study aims to investigate the prognostic value of the HSPG2 gene in terms of overall survival and leukemia-free survival in patients with AML. Bone marrow mononuclear cells (BMMCs) from 4 AML patients and 3 healthy controls were processed for RNA-Sequencing (RNA-seq). The mRNA expression level of HSPG2 in BMMCs and CD34 + hematopoietic stem/progenitor cells (HSPC) obtained from enrolled participants and human leukemic cell lines was detected by RT-qPCR. Then the correlations between the expression of HSPG2 and a variety of important clinical parameters, such as median white blood cell (WBC) count and bone marrow (BM) blasts, were further analyzed. The expression level of HSPG2 was significantly upregulated in AML patients at the time of diagnosis, downregulated after complete remission and then elevated again at relapse. Moreover, HSPG2 expression was associated with median WBC count ( P < 0.001), median hemoglobin ( P = 0.02), median platelet count ( P = 0.001), and BM blasts ( P < 0.001) in AML patients. Patients with high HSPG2 expression had both worse overall survival (OS) ( P = 0.001) and poorer leukemia-free survival (LFS) ( P = 0.047). In the multivariate analysis model, HSPG2 was identified as an independent prognostic biomarker of AML. Taken together, these results indicate that HSPG2 overexpression was associated with poor prognosis in AML patients, and may be a prognostic biomarker and therapeutic target of AML." @default.
• W3038961723 created "2020-07-10" @default.
• W3038961723 creator A5006340124 @default.
• W3038961723 creator A5012278873 @default.
• W3038961723 creator A5015257534 @default.
• W3038961723 creator A5036283284 @default.
• W3038961723 creator A5055242675 @default.
• W3038961723 creator A5091639270 @default.
• W3038961723 date "2020-06-30" @default.
• W3038961723 modified "2023-10-11" @default.
• W3038961723 title "HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia" @default.
• W3038961723 cites W1510578544 @default.
• W3038961723 cites W1964251746 @default.
• W3038961723 cites W1973275548 @default.
• W3038961723 cites W1991408379 @default.
• W3038961723 cites W1993958351 @default.
• W3038961723 cites W1995494201 @default.
• W3038961723 cites W2010936602 @default.
• W3038961723 cites W2018139894 @default.
• W3038961723 cites W2025491043 @default.
• W3038961723 cites W2037552037 @default.
• W3038961723 cites W2074751736 @default.
• W3038961723 cites W2108746805 @default.
• W3038961723 cites W2131577336 @default.
• W3038961723 cites W2140545872 @default.
• W3038961723 cites W2144308640 @default.
• W3038961723 cites W2148514581 @default.
• W3038961723 cites W2151616719 @default.
• W3038961723 cites W2152333235 @default.
• W3038961723 cites W2152786876 @default.
• W3038961723 cites W2156044485 @default.
• W3038961723 cites W2555384738 @default.
• W3038961723 cites W2591153485 @default.
• W3038961723 cites W2598071034 @default.
• W3038961723 cites W2782595700 @default.
• W3038961723 cites W2793853619 @default.
• W3038961723 cites W2901611684 @default.
• W3038961723 cites W2904467831 @default.
• W3038961723 cites W2909476806 @default.
• W3038961723 cites W2915860404 @default.
• W3038961723 cites W2953259441 @default.
• W3038961723 cites W2971587603 @default.
• W3038961723 cites W2991668335 @default.
• W3038961723 cites W2999080566 @default.
• W3038961723 cites W3005295900 @default.
• W3038961723 cites W3011919114 @default.
• W3038961723 cites W4231346141 @default.
• W3038961723 doi "https://doi.org/10.1038/s41419-020-2694-7" @default.
• W3038961723 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7327006" @default.
• W3038961723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32606327" @default.
• W3038961723 hasPublicationYear "2020" @default.
• W3038961723 type Work @default.
• W3038961723 sameAs 3038961723 @default.
• W3038961723 citedByCount "14" @default.
• W3038961723 countsByYear W30389617232021 @default.
• W3038961723 countsByYear W30389617232022 @default.
• W3038961723 countsByYear W30389617232023 @default.
• W3038961723 crossrefType "journal-article" @default.
• W3038961723 hasAuthorship W3038961723A5006340124 @default.
• W3038961723 hasAuthorship W3038961723A5012278873 @default.
• W3038961723 hasAuthorship W3038961723A5015257534 @default.
• W3038961723 hasAuthorship W3038961723A5036283284 @default.
• W3038961723 hasAuthorship W3038961723A5055242675 @default.
• W3038961723 hasAuthorship W3038961723A5091639270 @default.
• W3038961723 hasBestOaLocation W30389617231 @default.
• W3038961723 hasConcept C10205521 @default.
• W3038961723 hasConcept C109159458 @default.
• W3038961723 hasConcept C126322002 @default.
• W3038961723 hasConcept C143998085 @default.
• W3038961723 hasConcept C201750760 @default.
• W3038961723 hasConcept C203014093 @default.
• W3038961723 hasConcept C2778461978 @default.
• W3038961723 hasConcept C2778729363 @default.
• W3038961723 hasConcept C2779282312 @default.
• W3038961723 hasConcept C2780007613 @default.
• W3038961723 hasConcept C28328180 @default.
• W3038961723 hasConcept C502942594 @default.
• W3038961723 hasConcept C54355233 @default.
• W3038961723 hasConcept C71924100 @default.
• W3038961723 hasConcept C86803240 @default.
• W3038961723 hasConceptScore W3038961723C10205521 @default.
• W3038961723 hasConceptScore W3038961723C109159458 @default.
• W3038961723 hasConceptScore W3038961723C126322002 @default.
• W3038961723 hasConceptScore W3038961723C143998085 @default.
• W3038961723 hasConceptScore W3038961723C201750760 @default.
• W3038961723 hasConceptScore W3038961723C203014093 @default.
• W3038961723 hasConceptScore W3038961723C2778461978 @default.
• W3038961723 hasConceptScore W3038961723C2778729363 @default.
• W3038961723 hasConceptScore W3038961723C2779282312 @default.
• W3038961723 hasConceptScore W3038961723C2780007613 @default.
• W3038961723 hasConceptScore W3038961723C28328180 @default.
• W3038961723 hasConceptScore W3038961723C502942594 @default.
• W3038961723 hasConceptScore W3038961723C54355233 @default.
• W3038961723 hasConceptScore W3038961723C71924100 @default.
• W3038961723 hasConceptScore W3038961723C86803240 @default.
• W3038961723 hasIssue "6" @default.
• W3038961723 hasLocation W30389617231 @default.
• W3038961723 hasLocation W30389617232 @default.
• W3038961723 hasLocation W30389617233 @default.
• W3038961723 hasOpenAccess W3038961723 @default.

• next